These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8380523)

  • 1. Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.
    Singer TP; Ramsay RR; Sonsalla PK; Nicklas WJ; Heikkila RE
    Adv Neurol; 1993; 60():300-5. PubMed ID: 8380523
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
    Chiueh CC; Miyake H; Peng MT
    Adv Neurol; 1993; 60():251-8. PubMed ID: 8380519
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental model of Parkinson disease: mechanisms and anatomo- pathological characteristics of MPTP neurotoxicity].
    Herrero MT; Luquín MR; Obeso JA
    Arch Neurobiol (Madr); 1992; 55(4):175-82. PubMed ID: 1417423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic aspects of the behavior of MPTP and some analogues.
    Tipton KF; McCrodden JM; Sullivan JP
    Adv Neurol; 1993; 60():186-93. PubMed ID: 8420134
    [No Abstract]   [Full Text] [Related]  

  • 5. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
    Mash DC; Sanchez-Ramos J; Weiner WJ
    Adv Neurol; 1993; 60():133-9. PubMed ID: 8420130
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of MPTP toxicity.
    Przedborski S; Jackson-Lewis V
    Mov Disord; 1998; 13 Suppl 1():35-8. PubMed ID: 9613716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPTP and other Parkinson-inducing agents.
    Schapira AH
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):396-400. PubMed ID: 1623269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for the cause of Parkinson's disease].
    Langston JW
    Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
    [No Abstract]   [Full Text] [Related]  

  • 9. Saccade responses to dopamine in human MPTP-induced parkinsonism.
    Hotson JR; Langston EB; Langston JW
    Ann Neurol; 1986 Oct; 20(4):456-63. PubMed ID: 3491578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
    Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
    Sagi Y; Mandel S; Amit T; Youdim MB
    Neurobiol Dis; 2007 Jan; 25(1):35-44. PubMed ID: 17055733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
    Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
    Tsukahara T; Takeda M; Shimohama S; Ohara O; Hashimoto N
    Neurosurgery; 1995 Oct; 37(4):733-9; discussion 739-41. PubMed ID: 8559303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural stem cells, scaffolds, and chaperones.
    Steindler DA
    Nat Biotechnol; 2002 Nov; 20(11):1091-3. PubMed ID: 12410250
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
    Doty RL; Singh A; Tetrud J; Langston JW
    Ann Neurol; 1992 Jul; 32(1):97-100. PubMed ID: 1642478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.
    Bezard E; Dovero S; Bioulac B; Gross C
    Exp Neurol; 1997 Nov; 148(1):288-92. PubMed ID: 9398471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP-induced Parkinson-like disease in sheep: clinical and pathologic findings.
    Beale AM; Higgins RJ; Work TM; Bailey CS; Smith MO; Shinka T; Hammock BD
    J Environ Pathol Toxicol Oncol; 1989 Dec; 9(5-6):417-28. PubMed ID: 2637935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes and Parkinson's disease.
    Forno LS; DeLanney LE; Irwin I; Di Monte D; Langston JW
    Prog Brain Res; 1992; 94():429-36. PubMed ID: 1287728
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
    Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.